https://lynchsyndromeireland.com/2026/07/12/aspirin-for-cancer-prevention-in-individuals-with-lynch-syndrome-first-results-from-the-capp3-multicentrerandomised-double-blind-non-inferiority-trial/Lynch Syndrome Irelanden2026-07-12T09:15:24+00:00Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre,randomised, double-blind, non-inferiority trialhttps://lynchsyndromeireland.com/wp-content/uploads/2026/07/screenshot-2026-07-12-at-10.14.42.png?w=150